Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00053989 · OUTCOME

OS

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders · Source last updated 2020-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
1 year

What was measured

Overall survival with events defined as death due to any cause and censored patients are alive as of 1 year post HSC infusion

Groups in this outcome

All Patients

All patients enrolled on study

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients41

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Patients44Not reported2959Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        29
        upper Limit
        59
        value
        44
denoms
  1. counts
    1. group Id
      OG000
      value
      41
    units
    Participants
description
Overall survival with events defined as death due to any cause and censored patients are alive as of 1 year post HSC infusion
dispersion Type
95% Confidence Interval
groups
  1. description
    All patients enrolled on study
    id
    OG000
    title
    All Patients
param Type
NUMBER
reporting Status
POSTED
time Frame
1 year
title
OS
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice